Original New Drug Application Approvals by US FDA (16 - 30 June 2021)
New drug applications approved by US FDA as of 16-30 June 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Original New Drug Application Approvals by US FDA (16 - 30 June 2021)
01 Jul 2021
